Susan "Susie" Kane, PhD, is a Principal Scientist at CST, where she focuses on identifying and validating antibodies for applications such as immunohistochemistry, immunofluorescence, and flow cytometry, with an emphasis on targets of interest to cancer researchers. Dr Kane received her PhD in Biochemistry from the University of Glasgow and completed postdoctoral training at Dartmouth Medical School.
